Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 111
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Microb Pathog ; 193: 106771, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38969185

ABSTRACT

Despite modern advances in food hygiene, food poisoning due to microbial contamination remains a global problem, and poses a great threat to human health. Especially, Listeria monocytogenes and Staphylococcus aureus are gram-positive bacteria found on food-contact surfaces with biofilms. These foodborne pathogens cause a considerable number of food poisoning and infections annually. Ovomucin (OM) is a water-insoluble gel-type glycoprotein in egg whites. Enzymatic hydrolysis can be used to improve the bioactive properties of OM. This study aimed to investigate whether ovomucin hydrolysates (OMHs) produced using five commercial enzymes (Alcalase®, Bromelain, α-Chymotrypsin, Papain, and Pancreatin) can inhibit the biofilm formation of L. monocytogenes ATCC 15313, L. monocytogenes H7962, S. aureus KCCM 11593, and S. aureus 7. Particularly, OMH prepared with papain (OMPP; 500 µg/mL) significantly inhibited biofilm formation in L. monocytogenes ATCC 15313, L. monocytogenes H7962, S. aureus KCCM 11593, and S. aureus 7 by 85.56 %, 80.28 %, 91.70 %, and 79.00 %, respectively. In addition, OMPP reduced the metabolic activity, exopolysaccharide production (EPS), adhesion ability, and gene expression associated with the biofilm formation of these bacterial strains. These results suggest that OMH, especially OMPP, exerts anti-biofilm effects against L. monocytogenes and S. aureus. Therefore, OMPP can be used as a natural anti-biofilm agent to control food poisoning in the food industry.


Subject(s)
Anti-Bacterial Agents , Biofilms , Listeria monocytogenes , Ovomucin , Staphylococcus aureus , Biofilms/drug effects , Listeria monocytogenes/drug effects , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/pharmacology , Ovomucin/pharmacology , Ovomucin/metabolism , Hydrolysis , Bacterial Adhesion/drug effects , Papain/metabolism , Microbial Sensitivity Tests , Chymotrypsin/metabolism , Protein Hydrolysates/pharmacology , Protein Hydrolysates/metabolism
2.
Mol Biol Evol ; 33(8): 1921-36, 2016 08.
Article in English | MEDLINE | ID: mdl-27189557

ABSTRACT

The gel-forming mucins are large glycosylated proteins that are essential components of the mucus layers covering epithelial cells. Using novel methods of identifying mucins based on profile hidden Markov models, we have found a large number of such proteins in Metazoa, aiding in their classification and allowing evolutionary studies. Most vertebrates have 5-6 gel-forming mucin genes and the genomic arrangement of these genes is well conserved throughout vertebrates. An exception is the frog Xenopus tropicalis with an expanded repertoire of at least 26 mucins of this type. Furthermore, we found that the ovomucin protein, originally identified in chicken, is characteristic of reptiles, birds, and amphibians. Muc6 is absent in teleost fish, but we now show that it is present in animals such as ghost sharks, demonstrating an early origin in vertebrate evolution. Public RNA-Seq data were analyzed with respect to mucins in zebrafish, frog, and chicken, thus allowing comparison in regard of tissue and developmental specificity. Analyses of invertebrate proteins reveal that gel-forming-mucin type of proteins is widely distributed also in this group. Their presence in Cnidaria, Porifera, and in Ctenophora (comb jellies) shows that these proteins were present early in metazoan evolution. Finally, we examined the evolution of the FCGBP protein, abundant in mucus and related to gel-forming mucins in terms of structure and localization. We demonstrate that FCGBP, ubiquitous in vertebrates, has a conserved N-terminal domain. Interestingly, this domain is also present as an N-terminal sequence in a number of bacterial proteins.


Subject(s)
Cell Adhesion Molecules/genetics , Mucins/genetics , Amino Acid Sequence , Animals , Cell Adhesion Molecules/chemistry , Cell Adhesion Molecules/metabolism , Epithelial Cells/metabolism , Evolution, Molecular , Genome/genetics , Humans , Markov Chains , Mucin-6/chemistry , Mucin-6/genetics , Mucin-6/metabolism , Mucins/chemistry , Mucins/metabolism , Mucus , Ovomucin/chemistry , Ovomucin/genetics , Ovomucin/metabolism , Phylogeny , Sequence Analysis, RNA , Structure-Activity Relationship
3.
Appl Microbiol Biotechnol ; 100(4): 1579-1587, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26668029

ABSTRACT

The biosynthesis of secondary metabolites in fungi is catalyzed by enzymes encoded by genes linked in clusters that are frequently co-regulated at the transcriptional level. Formation of gene clusters may take place by de novo assembly of genes recruited from other cellular functions, but also novel gene clusters are formed by reorganization of progenitor clusters and are distributed by horizontal gene transfer. This article reviews (i) the published information on the roquefortine/meleagrin/neoxaline gene clusters of Penicillium chrysogenum (Penicillium rubens) and the short roquefortine cluster of Penicillium roqueforti, and (ii) the correlation of the genes present in those clusters with the enzymes and metabolites derived from these pathways. The P. chrysogenum roq/mel cluster consists of seven genes and includes a gene (roqT) encoding a 12-TMS transporter protein of the MFS family. Interestingly, the orthologous P. roquefortine gene cluster has only four genes and the roqT gene is present as a residual pseudogene that encodes only small peptides. Two of the genes present in the central region of the P. chrysogenum roq/mel cluster have been lost during the evolutionary formation of the short cluster and the order of the structural genes in the cluster has been rearranged. The two lost genes encode a N1 atom hydroxylase (nox) and a roquefortine scaffold-reorganizing oxygenase (sro). As a consequence P. roqueforti has lost the ability to convert the roquefortine-type carbon skeleton to the glandicoline/meleagrin-type scaffold and is unable to produce glandicoline B, meleagrin and neoxaline. The loss of this genetic information is not recent and occurred probably millions of years ago when a progenitor Penicillium strain got adapted to life in a few rich habitats such as cheese, fermented cereal grains or silage. P. roqueforti may be considered as a "domesticated" variant of a progenitor common to contemporary P. chrysogenum and related Penicillia.


Subject(s)
Alkaloids/metabolism , Gene Rearrangement , Indoles/metabolism , Metabolic Networks and Pathways/genetics , Multigene Family , Ovomucin/metabolism , Penicillium/genetics , Evolution, Molecular , Heterocyclic Compounds, 4 or More Rings/metabolism , Piperazines/metabolism
4.
Poult Sci ; 94(9): 2280-7, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26195809

ABSTRACT

Ovomucoid is well known as a "trypsin inhibitor" and is considered to be the main food allergen in egg. However, the negative functions of ovomucoid can be eliminated if the protein is cut into small peptides. The objectives of this study were to hydrolyze ovomucoid using various enzyme combinations, and compare the functional properties of the hydrolysates. Purified ovomucoid was dissolved in distilled water (20 mg/mL) and treated with 1% of pepsin, α-chymotrypsin, papain, and alcalase, singly or in combinations. Sodium sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) results of the hydrolysates indicated that pepsin (OMP), alcalase (OMAl), alcalase+trypsin (OMAlTr), and alcalase+papain (OMAlPa) treatments best hydrolyzed the ovomucoid, and the 4 treatments were selected to determine their functional characteristics. Among the 4 enzyme treatments, hydrolysate from OMAlTr showed the highest iron-chelating and antioxidant activities, while OMP showed higher ACE-inhibitory activity, but lower Fe-chelating activity than the other treatments. However, no difference in the copper-chelating activity among the treatments was found. MS/MS analysis identified numerous peptides from the hydrolysates of OMAlPa and OMAlTr, and majority of the peptides produced were <2 kDa. Pepsin treatment (OMP), however, hydrolyzed ovomucoid almost completely and produced only amino acid monomers, di- and tri-peptides. The ACE-inhibitory, antioxidant and iron-chelating activities of the enzyme hydrolysates were not consistent with the number and size of peptides in the hydrolysates, but we do not have information about the quantity of each peptide present in the hydrolysates at this point.


Subject(s)
Avian Proteins/chemistry , Avian Proteins/metabolism , Chickens/metabolism , Ovomucin/chemistry , Ovomucin/metabolism , Ovum/chemistry , Angiotensin-Converting Enzyme Inhibitors/analysis , Animals , Antioxidants/analysis , Chelating Agents/analysis , Electrophoresis, Polyacrylamide Gel , Endopeptidases/chemistry , Endopeptidases/metabolism , Hydrolysis , Metals/chemistry , Peptides/chemistry , Peptides/metabolism , Tandem Mass Spectrometry
5.
Am J Physiol Gastrointest Liver Physiol ; 306(5): G412-24, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-24407591

ABSTRACT

We previously reported that Rab1a is associated with asialoorosomucoid (ASOR)-containing early endocytic vesicles, where it is required for their microtubule-based motility. In Rab1a knockdown (KD) cell lines, ASOR failed to segregate from its receptor and, consequently, did not reach lysosomes for degradation, indicating a defect in early endosome sorting. Although Rab1 is required for Golgi/endoplasmic reticulum trafficking, this process was unaffected, likely due to retained expression of Rab1b in these cells. The present study shows that Rab1a has a more general role in endocytic vesicle processing that extends to EGF and transferrin (Tfn) trafficking. Compared with results in control Huh7 cells, EGF accumulated in aggregates within Rab1a KD cells, failing to reach lysosomal compartments. Tfn, a prototypical example of recycling cargo, accumulated in a Rab11-mediated slow-recycling compartment in Rab1a KD cells, in contrast to control cells, which sort Tfn into a fast-recycling Rab4 compartment. These data indicate that Rab1a is an important regulator of early endosome sorting for multiple cargo species. The effectors and accessory proteins recruited by Rab1a to early endocytic vesicles include the minus-end-directed kinesin motor KifC1, while others remain to be discovered.


Subject(s)
Gene Expression Regulation/physiology , Transport Vesicles/physiology , rab1 GTP-Binding Proteins/metabolism , Asialoglycoproteins/metabolism , Biological Transport , Cell Line, Tumor , Endocytosis , Fluorescent Antibody Technique , Gene Knockdown Techniques , Humans , Kinesins/genetics , Kinesins/metabolism , Ovomucin/metabolism , rab1 GTP-Binding Proteins/genetics
6.
Int J Biol Macromol ; 270(Pt 1): 132295, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38735615

ABSTRACT

Ovomucin-Complex extracted from egg white is expected to have a barrier function similar to gastric mucin. In this study, the dynamic changes in structure, rheological properties and binding ability of Ovomucin-Complex during in vitro simulated gastric digestion were investigated. The results from HPLC and CLSM showed that extremely acidic pH (pH = 2.0) promoted Ovomucin-Complex to form aggregation. Acid-induced aggregation may hinder its binding to pepsin, thus rendering Ovomucin-Complex resistant to pepsin. Consequently, most of the polymer structure and weak gel properties of Ovomucin-Complex retained after simulated gastric digestion as verified by HPLC, CLSM and rheological measurement, although there was a small breakdown of the glycosidic bond as confirmed by the increased content of reducing sugar. The significantly reduced hydrophobic interactions of Ovomucin-Complex were observed under extremely acidic conditions and simulated gastric digestion compared with the native. Noticeably, the undigested Ovomucin-Complex after simulated gastric digestion showed a higher affinity (KD = 5.0 ± 3.2 nm) for urease - the key surface antigen of Helicobacter pylori. The interaction mechanism between Ovomucin-Complex and urease during gastric digestion deserves further studies. This finding provides a new insight to develop an artificial physical mucus barrier to reduce Helicobacter pylori infection.


Subject(s)
Digestion , Ovomucin , Urease , Urease/metabolism , Urease/chemistry , Ovomucin/chemistry , Ovomucin/metabolism , Hydrogen-Ion Concentration , Protein Binding , Pepsin A/metabolism , Pepsin A/chemistry , Polymerization , Helicobacter pylori , Rheology , Humans
7.
Food Funct ; 15(1): 196-207, 2024 Jan 02.
Article in English | MEDLINE | ID: mdl-38047408

ABSTRACT

Ovomucoid is the immune-dominant allergen in the egg white of hens. Due to its structure based on nine disulfide bonds as well as its resistance to heat and enzymatic hydrolysis, the allergenicity of this food protein is difficult to decrease by technological processes. We sought to reduce its allergenicity through the Maillard reaction. The unfolding of ovomucoid with L-cysteine-mediated reduction was used to increase accessibility to conformational and linear epitopes by modifying the secondary and tertiary structures of the allergen. Glycation with different saccharides revealed the beneficial effect of maltose glycation on the IgG-binding capacity reduction. By determining the better glycation conditions of unfolded ovomucoid, we produced ovomucoid with reduced IgE binding capacity due to the glycation sites (K17, K112, K129, and K164) on epitopes. Moreover, after simulated infant and adult gastrointestinal digestion, the unfolded plus glycated ovomucoid showed higher ABTS˙+ scavenging activity, O2˙- scavenging activity, ˙OH scavenging activity, Fe2+ chelating activity, and a FRAP value; in particular, for ˙OH scavenging activity, there was a sharp increase of more than 100%.


Subject(s)
Maillard Reaction , Ovomucin , Humans , Infant , Adult , Animals , Female , Ovomucin/chemistry , Ovomucin/metabolism , Antioxidants , Chickens/metabolism , Epitopes/chemistry , Allergens/chemistry , Immunoglobulin E/chemistry , Immunoglobulin G/chemistry
8.
Proteins ; 81(4): 704-14, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23239118

ABSTRACT

Understanding the effects of mutation on pH-dependent protein binding affinity is important in protein design, especially in the area of protein therapeutics. We propose a novel method for fast in silico mutagenesis of protein-protein complexes to calculate the effect of mutation as a function of pH. The free energy differences between the wild type and mutants are evaluated from a molecular mechanics model, combined with calculations of the equilibria of proton binding. The predicted pH-dependent energy profiles demonstrate excellent agreement with experimentally measured pH-dependency of the effect of mutations on the dissociation constants for the complex of turkey ovomucoid third domain (OMTKY3) and proteinase B. The virtual scanning mutagenesis identifies all hotspots responsible for pH-dependent binding of immunoglobulin G (IgG) to neonatal Fc receptor (FcRn) and the results support the current understanding of the salvage mechanism of the antibody by FcRn based on pH-selective binding. The method can be used to select mutations that change the pH-dependent binding profiles of proteins and guide the time consuming and expensive protein engineering experiments. As an application of this method, we propose a computational strategy to search for mutations that can alter the pH-dependent binding behavior of IgG to FcRn with the aim of improving the half-life of therapeutic antibodies in the target organism.


Subject(s)
Histocompatibility Antigens Class I/metabolism , Immunoglobulin G/metabolism , Ovomucin/metabolism , Receptors, Fc/metabolism , Serine Endopeptidases/metabolism , Animals , Computer Simulation , Histocompatibility Antigens Class I/genetics , Humans , Hydrogen-Ion Concentration , Immunoglobulin G/genetics , Mutagenesis , Mutation , Ovomucin/genetics , Protein Binding , Receptors, Fc/genetics , Serine Endopeptidases/genetics , Thermodynamics , Turkey
9.
Ultrason Sonochem ; 89: 106153, 2022 Sep.
Article in English | MEDLINE | ID: mdl-36088894

ABSTRACT

The effects of ultrasonic treatment on the structure, functional properties and bioactivity of Ovomucin (OVM) were investigated in this study. Ultrasonic treatment could significantly enhance OVM solubility without destroying protein molecules. The secondary structure changes, including ß-sheet reduction and random coil increase, indicate more disorder in OVM structure. After ultrasonic treatment, the OVM molecule was unfolded partially, resulting in the exposure of hydrophobic regions. The changes in OVM molecules led to an increase in intrinsic fluorescence and surface hydrophobicity. By detecting the particle size of protein solution, it was confirmed that ultrasonic treatment disassembled the OVM aggregations causing a smaller particle size. Field emission scanning electron microscopy (FE-SEM) images showed that ultrasonic cavitation significantly reduced the tendency of OVM to form stacked lamellar structure. Those changes in structure resulted in the improvement of foaming, emulsification and antioxidant capacity of OVM. Meanwhile, the detection results of ELISA showed that ultrasonic treatment did not change the biological activity of OVM. These results suggested that the relatively gentle ultrasound treatment could be utilized as a potential approach to modify OVM for property improvement.


Subject(s)
Ovomucin , Ultrasonics , Antioxidants , Enzyme-Linked Immunosorbent Assay , Hydrophobic and Hydrophilic Interactions , Ovomucin/chemistry , Ovomucin/metabolism
10.
Proteins ; 79(12): 3420-36, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22002801

ABSTRACT

We propose a new algorithm for obtaining proton titration curves of ionizable residues. The algorithm is a pH replica-exchange method (PHREM), which is based on the constant pH algorithm of Mongan et al. (J Comput Chem 2004;25:2038-2048). In the original replica-exchange method, simulations of different replicas are performed at different temperatures, and the temperatures are exchanged between the replicas. In our PHREM, simulations of different replicas are performed at different pH values, and the pHs are exchanged between the replicas. The PHREM was applied to a blocked amino acid and to two protein systems (snake cardiotoxin and turkey ovomucoid third domain), in conjunction with a generalized Born implicit solvent. The performance and accuracy of this algorithm and the original constant pH method (PHMD) were compared. For a single set of simulations at different pHs, the use of PHREM yields more accurate Hill coefficients of titratable residues. By performing multiple sets of constant pH simulations started with different initial states, the accuracy of predicted pK(a) values and Hill coefficients obtained with PHREM and PHMD methods becomes comparable. However, the PHREM algorithm exhibits better samplings of the protonation states of titratable residues and less scatter of the titration points and thus better precision of measured pK(a) values and Hill coefficients. In addition, PHREM exhibits faster convergence of individual simulations than the original constant pH algorithm.


Subject(s)
Cobra Cardiotoxin Proteins/metabolism , Models, Chemical , Ovomucin/metabolism , Algorithms , Amino Acids/chemistry , Amino Acids/metabolism , Cobra Cardiotoxin Proteins/chemistry , Computer Simulation , Hydrogen-Ion Concentration , Models, Molecular , Ovomucin/chemistry , Protein Conformation , Protein Structure, Tertiary , Proteins/chemistry , Proteins/metabolism , Protons , Static Electricity , Temperature
11.
Biosci Biotechnol Biochem ; 75(10): 1872-9, 2011.
Article in English | MEDLINE | ID: mdl-21979059

ABSTRACT

Thioredoxin (TRX) catalyzes the reduction of disulfide bonds in proteins via the NADPH-dependent thioredoxin reductase system. Reducing the disulfide bonds of allergenic proteins in food by TRX lowers the allergenicity. We established in this study a method to prepare TRX-enriched extracts from the edible yeast, Saccharomyces cerevisiae, on a large and practical scale, with the objective of developing TRX-containing functional foods to mitigate food allergy. Treating with the yeast TRX-enriched extracts together with NADPH and yeast thioredoxin reductase enhanced the pepsin cleavage of ß-lactoglobulin and ovomucoid (OM). We also examined whether yeast TRX can mitigate the allergenicity of OM by conducting immediate allergy tests on guinea pigs. The treatment with TRX reduced the anaphylactic symptoms induced by OM in these tests. These results indicate that yeast TRX was beneficial against food allergy, raising the possibility that yeast TRX-enriched extracts can be applied to food materials for mitigating food allergy.


Subject(s)
Allergens/immunology , Allergens/metabolism , Food Hypersensitivity/immunology , Functional Food , Fungal Proteins/metabolism , Saccharomyces cerevisiae/chemistry , Thioredoxins/metabolism , Anaphylaxis/immunology , Animals , Antibodies/immunology , Female , Food Hypersensitivity/prevention & control , Functional Food/toxicity , Guinea Pigs , Humans , Lactoglobulins/immunology , Lactoglobulins/metabolism , Male , Mice , Ovomucin/immunology , Ovomucin/metabolism , Passive Cutaneous Anaphylaxis/immunology , Protein Isoforms/metabolism
12.
J Chem Phys ; 133(9): 095101, 2010 Sep 07.
Article in English | MEDLINE | ID: mdl-20831336

ABSTRACT

In this paper, we used a coarse-grained model at the residue level to calculate the binding free energies of three protein-protein complexes. General formulations to calculate the electrostatic binding free energy and the van der Waals free energy are presented by solving linearized Poisson-Boltzmann equations using the boundary element method in combination with the fast multipole method. The residue level model with the fast multipole method allows us to efficiently investigate how the mutations on the active site of the protein-protein interface affect the changes in binding affinities of protein complexes. Good correlations between the calculated results and the experimental ones indicate that our model can capture the dominant contributions to the protein-protein interactions. At the same time, additional effects on protein binding due to atomic details are also discussed in the context of the limitations of such a coarse-grained model.


Subject(s)
Protein Interaction Mapping/methods , Proteins/metabolism , Animals , Aprotinin/metabolism , Bacillus/enzymology , Bacterial Proteins/metabolism , Cattle , Models, Biological , Ovomucin/metabolism , Protein Binding , Protein Interaction Mapping/economics , Proteins/chemistry , Ribonucleases/metabolism , Serine Endopeptidases/metabolism , Streptomyces griseus/enzymology , Thermodynamics , Trypsin/metabolism , Turkey
13.
Int J Biol Macromol ; 162: 385-393, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-32569696

ABSTRACT

Intestinal dysfunction, which may cause a series of metabolic diseases, has become a worldwide health problem. In the past few years, studies have shown that consumption of poultry eggs has the potential to prevent a variety of metabolic diseases, and increasing attention has been directed to the bioactive proteins and their peptides in poultry eggs. This review mainly focused on the biological activities of an important egg-derived protein named ovomucin. Ovomucin and its derivatives have good anti-inflammatory, antioxidant, immunity-regulating and other biological functions. These activities may affect the physical, biological and immune barriers associated with intestinal health. This paper reviewed the structure and the structure-activity relationship of ovomucin,the potential role of ovomucin and its derivatives in modulation of intestinal health are also summarized. Finally, the potential applications of ovomucin and its peptides as functional food components to prevent and assist in the pretreatment of intestinal health problems are prospected.


Subject(s)
Anti-Inflammatory Agents/metabolism , Antioxidants/metabolism , Chickens/metabolism , Egg Proteins/metabolism , Gastrointestinal Microbiome , Intestinal Mucosa/metabolism , Ovomucin/metabolism , Animals , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Eggs , Intestinal Mucosa/immunology , N-Acetylneuraminic Acid/metabolism , Ovomucin/chemistry , Ovomucin/immunology , Peptides/chemistry , Peptides/metabolism , Poultry , Structure-Activity Relationship
14.
J Cell Biol ; 92(1): 139-46, 1982 Jan.
Article in English | MEDLINE | ID: mdl-6799523

ABSTRACT

The distribution of galactosyl transferase was studied using trans and cis Golgi fractions isolated by a modification of the Ehrenreich et al. procedure (1973. J. Cell Biol. 59:45-72) as well as an intact Golgi fraction isolated by a new one-step procedure. Two methods of assay were used. The first method analyzed the ability of Golgi fractions to transfer galactose (from uridine diphosphogalactose [UDP-gal] substrate) to the defined exogenous acceptor ovomucoid. The second method assessed the transfer of galactose from UDP-gal substrate to endogenous acceptors (endogenous glycosylation). The trans Golgi fraction (Golgi light) was highly active by the first method but revealed only low activity by the second method. Golgi fractions enriched in central and cis elements (the Golgi intermediate, heavy and especially the intact Golgi fraction) were highly active in both methods of assay. The endogenous glycosylation approach was validated by gel fluorography of the endogenous acceptors. For all Golgi fractions, transfer of galactose was revealed to secretory glycopeptides. It is concluded that galactosyl transferase activity in vivo occurs primarily in central and cis Golgi elements but not trans Golgi vesicles.


Subject(s)
Galactosyltransferases/metabolism , Golgi Apparatus/physiology , Animals , Cell Fractionation/methods , Glycoproteins/metabolism , Golgi Apparatus/ultrastructure , Ovomucin/metabolism , Rats , Substrate Specificity
15.
J Cell Biol ; 123(6 Pt 2): 1695-706, 1993 Dec.
Article in English | MEDLINE | ID: mdl-7506265

ABSTRACT

Previous experiments led us to speculate that thyrocytes contain a recycling system for GlcNAc-bearing immature thyroglobulin molecules which prevents these molecules from lysosomal degradation (Miquelis, R., C. Alquier, and M. Monsigny. 1987. J. Biol. Chem. 262:15291-15298). To confirm this hypothesis, the fate of GlcNAc-bearing proteins after internalization by thyrocytes was monitored and compared to that of fluid phase markers. Kinetic internalization studies were performed using 125I-GlcNAc-BSA and 131I-Man-BSA. We observed that the apparent intake rate as well as the amount of hydrolyzed GlcNAc-BSA are smaller than the corresponding values for Man-BSA. These differences were reduced by GlcNAc competitors (thyroglobulin and ovomucoid) or a weak base (chloroquine). Part of the internalized GlcNAc-BSA was released into the extracellular milieu at a higher rate and shorter half life (t1/2 = approximately 30 min) than the Man-BSA (t1/2 = approximately 8 h). Subcellular homing was first studied by cell fractionation after internalization using 125I-ovomucoid and 131I-BSA. During Percoll density gradient fractionation, endogenous thyroperoxidase was used to separate subsets of organelles involved in the biosynthetic exocytotic pathway. Incubation of the cell homogenate in the presence of DAB and H2O2 before cell fractionation give rise to a shift in the density of organelles containing 3.5 times more ovomucoid than BSA. Discontinuous sucrose gradient showed that: (a) thyroperoxidase was colocalized with galactosyltransferase-contraining organelles in Golgi-rich subfractions; and (b) that at every time studied from 10 to 100 min, the ovomucoid/BSA ratio was higher in these organelles than in other subfractions. Finally we also observed that: (a) ovomucoid sequestered in the Golgi-rich subfraction incorporated [3H]galactose; and (b) that part of internalized ovomucoid was localized on the Golgi stacks as well as elements of the trans-Golgi, as revealed by immunogold labeling on ultrathin cryosections. These data prove that in thyrocytes GlcNAc accessible sugar moieties on soluble internalized molecules are sufficient to trigger their recycling via the Golgi apparatus.


Subject(s)
Acetylglucosamine/analogs & derivatives , Acetylglucosamine/metabolism , Glycoproteins/metabolism , Golgi Apparatus/metabolism , Mannose/metabolism , Serum Albumin, Bovine/metabolism , Serum Albumin/metabolism , Thyroid Gland/metabolism , Animals , Cell Fractionation , Centrifugation, Density Gradient , Chloroquine/pharmacology , Galactose/metabolism , Galactosyltransferases/metabolism , Golgi Apparatus/ultrastructure , Iodine Radioisotopes , Kinetics , Microscopy, Immunoelectron , Ovomucin/metabolism , Ovomucin/pharmacology , Swine , Thyroglobulin/pharmacology , Thyroid Gland/ultrastructure , Time Factors , alpha-Fetoproteins/pharmacology
16.
J Allergy Clin Immunol ; 122(3): 583-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18692888

ABSTRACT

BACKGROUND: Children with allergy to raw egg white might tolerate low amounts of heated egg. Ovomucoid-specific IgE antibodies have been suggested to be predictors of whether children could tolerate heat-treated egg. OBJECTIVE: The aim was to evaluate the clinical usefulness and added diagnostic value of measurements of IgE antibodies to egg white, ovalbumin, and ovomucoid in children with egg allergy. METHODS: One hundred eight patients (median age, 34.5 months) with suspected egg allergy underwent double-blind, placebo-controlled food challenges with raw and heated egg. The outcomes of the challenges were related to the serum concentration of specific IgE antibodies and total IgE by using ImmunoCAP. RESULTS: Reactions to heated egg white were observed in 38 patients (considered allergic to raw and heated egg), 29 patients reacted to only raw egg white, and 41 patients were tolerant. Correlation was observed between the serologic parameters studied. Receiver operating characteristic analysis showed that egg white ImmunoCAP was useful in the diagnosis of allergy to raw egg white. The positive decision point, based on 95% clinical specificity, was 7.4 kU(A)/L, and the negative decision point, based on 95% clinical sensitivity, was 0.6 kU(A)/L. For reaction to heated egg white, ovomucoid ImmunoCAP was superior. The positive decision point was 10.8 kU(A)/L, and the negative decision point was 1.2 kU(A)/L. CONCLUSIONS: Quantitative measurements of specific IgE antibodies to both egg white and ovomucoid and the evaluation against the suggested positive and negative decision points for specific IgE will be useful in the diagnosis of egg allergy.


Subject(s)
Egg Hypersensitivity/diagnosis , Egg White/adverse effects , Immunoglobulin E/blood , Ovalbumin/immunology , Ovomucin/immunology , Adolescent , Child , Child, Preschool , Egg Hypersensitivity/immunology , Female , Humans , Immunoassay , Infant , Male , Ovalbumin/metabolism , Ovomucin/metabolism , Sensitivity and Specificity
17.
Food Chem ; 263: 135-141, 2018 Oct 15.
Article in English | MEDLINE | ID: mdl-29784298

ABSTRACT

Egg white thinning during ambient storage is a well-known phenomenon. The objective of the study was to characterize the formation of peptides <10 kDa in egg white during storage at room temperature. The results indicated that the content of peptides in the egg white fraction of <10 kDa increased gradually. Similar but a faster trend was observed for the fraction of <3 kDa. Gallin, also called ovodefensin (∼7 kDa), was the main component in 10-3 kDa egg white fraction, which rapidly degraded and disappeared at 28 d of storage. Mass spectrometry analysis of <3 kDa fraction identified 6 peptide fragments from ovotransferrin and 11 peptides from ovomucin. Ovodefensin, ovotransferrin and ovomucin are the major innate components of egg defense; thus the degradation of these proteins during storage contributes to egg white thinning and increased susceptibility to bacterial contamination. This study provides the insights on the molecular mechanism of egg deterioration during prolonged ambient storage.


Subject(s)
Egg White/chemistry , Food Storage/methods , Peptides/chemistry , Animals , Chickens , Conalbumin/chemistry , Conalbumin/metabolism , Mass Spectrometry , Ovomucin/chemistry , Ovomucin/metabolism , Peptides/metabolism , Tandem Mass Spectrometry , Temperature
18.
Int J Biol Macromol ; 119: 533-539, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30071221

ABSTRACT

Ovomucin (OVM) plays an important role in inhibiting infection of various pathogens. However, this bioactivity mechanism is not much known. Here, the role of sialic acid in OVM anti-virus activity has been studied by ELISA with lectin or ligand. Structural changes of OVM after removing sialic acid were analyzed by circular dichroism and fluorescence spectroscopy. OVM could be binding to the hemagglutinin (HA) of avian influenza viruses H5N1 and H1N1, this binding was specific and required the involvement of sialic acid. When sialic acid was removed, the binding was significantly reduced 71.5% and 64.35%, respectively. Therefore, sialic acid was proved as a recognition site which avian influenza virus bound to. Meanwhile, the endogenous fluorescence and surface hydrophobicity of OVM removing sialic acid were increased and the secondary structure tended to shift to random coil. This indicated that OVM molecules were in an unfolded state and spatial conformation disorder raising weakly. Remarkably, free sialic acid strongly promoted OVM binding to HA and thereby enhanced the interaction. It may contribute to the inhibition of host cell infection, agglutinate viruses. This study can be extended to the deepening of passive immunization field.


Subject(s)
Antiviral Agents/chemistry , Antiviral Agents/metabolism , Hemagglutinins/metabolism , N-Acetylneuraminic Acid/metabolism , Ovomucin/chemistry , Ovomucin/metabolism , Antiviral Agents/pharmacology , Influenza A Virus, H1N1 Subtype/drug effects , Influenza A Virus, H1N1 Subtype/metabolism , Influenza A Virus, H5N1 Subtype/drug effects , Influenza A Virus, H5N1 Subtype/metabolism , Ovomucin/pharmacology
19.
Food Chem ; 212: 78-86, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27374509

ABSTRACT

Ovomucin, accounting for ∼3.5% of egg white proteins, contains 2.6-7.4% of sialic acid; sialic acid is suggested to play important roles in host-recognition, cognition and memory development. However, ovomucin's limited water solubility might restrict its future applications. The objective of the study was to examine the effect of proteolysis of ovomucin on the sialic acid content and bifidogenic activity of ovomucin hydrolysates. Ovomucin extract was hydrolyzed by 14 proteases with yields and DHs ranging from 42.6% (flavourzyme) to 97.4% (protease N), and 2.4% (flavourzyme) to 46.3% (pronase), respectively. Ovomucin hydrolyzed by pronase and protex 26L showed molecular weight (Mw) distributions less than 40kDa while others larger than 200kDa. Allergenicity of ovomucin hydrolysates was significantly reduced (P<0.05) in comparison to ovomucin extract. The content of sialic acid in hydrolysates ranged from 0.1% (protex 26L) to 3.7% (pronase). Ovomucin hydrolysates did not generally support growth of Bifidobacterium spp. in vitro.


Subject(s)
N-Acetylneuraminic Acid/metabolism , Ovomucin/metabolism , Endopeptidases/metabolism , Hydrolysis , Peptide Hydrolases/metabolism , Proteolysis
20.
Biochim Biophys Acta ; 1076(3): 343-50, 1991 Feb 15.
Article in English | MEDLINE | ID: mdl-2001382

ABSTRACT

The urea and heat-induced unfolding-refolding behaviours of chicken egg white ovomucoid and its four fragments representing domains I, II + III, I + II and III were systematically investigated in 0.06 M sodium phosphate buffer (pH 7.0) by difference spectral measurements. The effect of temperature on ovomucoid and its fragments was also studied in 0.05 M sodium acetate buffer (pH 5.0) and in presence of 2 M urea at pH 7.0. Intrinsic viscosity data showed that ovomucoid and its different fragments did not lose any significant amount of their structure under mild acidic conditions (pH 4.6). Difference spectral results showed extensive disruption of the native structure by urea or temperature. Isothermal transitions showed single-step for domain I, domain I + II and domain III, and two-step having one stable intermediate, for ovomucoid and its fragment representing domain II + III. However, the presence of intermediate was not detected when the transitions were studied with temperature at pH 7.0. Strikingly, the single-step thermal transitions of ovomucoid and its fragment representing domain II + III, became two-step when measured either at pH 5.0 or in presence of 2 M urea at pH 7.0. Analysis of the equilibrium data on urea and heat denaturation showed that the second transition observed with ovomucoid or domain II + III represent the unfolding of domain III. The kinetic results of ovomucoid and its fragments indicate that the protein unfolds with three kinetic phases. A comparison of three rate constants for the unfolding of intact ovomucoid with that of its various fragments revealed that domain I, II and III of the protein correspond to the three kinetic phases having rate constants 0.456, 0.120 and 0.054 min-1, respectively. These data have led us to conclude: (i) the unusual stability of ovomucoid towards various denaturants, including temperature, is due to its domain III, (ii) initiation of the folding of the ovomucoid molecule starts from its NH2-terminal region which probably provides the nucleation site for the formation of the subsequent structure and (iii) domains I and II have greater mutual recognition between them as compared to the recognition either of them have with domain III.


Subject(s)
Ovomucin/metabolism , Animals , Chickens , Egg White , Guanidine , Guanidines/pharmacology , Hydrogen-Ion Concentration , Kinetics , Ovomucin/chemistry , Protein Conformation , Protein Denaturation , Spectrophotometry, Ultraviolet , Thermodynamics , Urea/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL